- Home
- TBBB vs DNLI Comparison
TBBB vs DNLI Comparison
Compare TBBB & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TBBB
- DNLI
- Stock Information
- Founded
- TBBB 2004
- DNLI 2013
- Country
- TBBB Mexico
- DNLI United States
- Employees
- TBBB N/A
- DNLI N/A
- Industry
- TBBB
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TBBB
- DNLI Health Care
- Exchange
- TBBB NYSE
- DNLI Nasdaq
- Market Cap
- TBBB 3.3B
- DNLI 3.3B
- IPO Year
- TBBB 2024
- DNLI 2017
- Fundamental
- Price
- TBBB $29.51
- DNLI $21.93
- Analyst Decision
- TBBB Buy
- DNLI Strong Buy
- Analyst Count
- TBBB 7
- DNLI 13
- Target Price
- TBBB $29.86
- DNLI $38.91
- AVG Volume (30 Days)
- TBBB 672.0K
- DNLI 1.1M
- Earning Date
- TBBB 02-12-2025
- DNLI 02-25-2025
- Dividend Yield
- TBBB N/A
- DNLI N/A
- EPS Growth
- TBBB N/A
- DNLI N/A
- EPS
- TBBB 0.12
- DNLI N/A
- Revenue
- TBBB $2,727,305,465.00
- DNLI N/A
- Revenue This Year
- TBBB $34.01
- DNLI N/A
- Revenue Next Year
- TBBB $29.24
- DNLI $651.24
- P/E Ratio
- TBBB $248.42
- DNLI N/A
- Revenue Growth
- TBBB 29.70
- DNLI 204.74
- 52 Week Low
- TBBB $18.71
- DNLI $14.56
- 52 Week High
- TBBB $35.22
- DNLI $33.33
- Technical
- Relative Strength Index (RSI)
- TBBB N/A
- DNLI 51.28
- Support Level
- TBBB N/A
- DNLI $18.52
- Resistance Level
- TBBB N/A
- DNLI $22.37
- Average True Range (ATR)
- TBBB 0.00
- DNLI 1.31
- MACD
- TBBB 0.00
- DNLI 0.31
- Stochastic Oscillator
- TBBB 0.00
- DNLI 88.57
About TBBB BBB FOODS INC
BBB Foods Inc is a company offering grocery hard discount model in Mexico. Also that operates through three subsidiaries namely Tiendas Tres B , Tiendas BBB and Desarrolladora Tres BSA de CV of which the main activity of Tiendas Tres B is the sale, purchase, distribution and marketing of all types of products, items and goods, as well as the establishment, and operation of individual stores and distribution centers for the sale of such products.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.